M. Zühlsdorf

Merck (Germany) — Germany

Medicine · Health Sciences

22h-index1.7kcitations82works1.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Myeloid Leukemia Research(32), Neutropenia and Cancer Infections(21), Hematopoietic Stem Cell Transplantation(11), Acute Lymphoblastic Leukemia research(10), Antifungal resistance and susceptibility(8)

Publications81 total

Spatial profiling of METex14-altered NSCLC under tepotinib treatment: Shifting the immunosuppressive landscape
Neoplasia·2024· 1 citedOpen Access
Mapping combinatorial drug effects to DNA damage response kinase inhibitors
Nature Communications·2023· 11 citedOpen Access
RosettaSX: Reliable gene expression signature scoring of cancer models and patients
Neoplasia·2021· 6 citedOpen Access
Aufklärung des Tumorpatienten: Weichenstellung für den Umgang mit Krebs
Deutsches Ärzteblatt·2017· 1 citedOpen Access
Population pharmacokinetics of cilengitide in adult and pediatric cancer patients from a nonlinear mixed‐effects analysis
The Journal of Clinical Pharmacology·2014· 1 cited
Safety, tolerability, and pharmacokinetics of the novel αv-integrin antibody EMD 525797 (DI17E6) in healthy subjects after ascending single intravenous doses
Investigational New Drugs·2013· 22 citedOpen Access
A Multicenter Phase 1 Study of EMD 525797 (DI17E6), a Novel Humanized Monoclonal Antibody Targeting αv Integrins, in Progressive Castration-resistant Prostate Cancer with Bone Metastases After Chemotherapy
European Urology·2013· 41 cited
A Phase 1 Study of EMD 525797 (DI17E6), A Humanized Monoclonal Antibody to Human AV Integrins, in CRPC with Bone Metastases After Chemotherapy
Annals of Oncology·2012
Concentration-Effect Relationships of Alcohol in a Computerised Psychometric Test System
Arzneimittelforschung·2011· 1 cited
Abstract 1296: Safety, tolerability, and pharmacokinetics of the novel αv-integrin antibody DI17E6 in healthy subjects after ascending single intravenous doses
Cancer Research·2011· 2 cited
Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis
Annals of Oncology·2008· 40 citedOpen Access
In vivo optical imaging of CD13/APN-expression in tumor xenografts
Journal of Biomedical Optics·2008· 67 citedOpen Access
Identification of acute myeloid leukaemia associated microRNA expression patterns
British Journal of Haematology·2007· 77 citedOpen Access
Use of Palifermin for the Prevention of High-Dose Methotrexate-Induced Oral Mucositis.
Blood·2007
Subcutaneous Zygomycosis in Neutropenia
Journal of Clinical Oncology·2007· 2 citedOpen Access
Bevacizumab reduces VEGF expression in patients with relapsed and refractory acute myeloid leukemia without clinical antileukemic activity
Leukemia·2007· 79 cited
In vivo Fluoreszenzbildgebung der CD13/APN-Expression im Tumor-Xenograft
RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren·2007
In vivo imaging of integrin ανβ3 expression using fluorescence-mediated tomography
European Journal of Nuclear Medicine and Molecular Imaging·2006· 66 cited
CMR 2005: 7.01: Planar and tomographic imaging of expression in human tumor xenografts
Contrast Media & Molecular Imaging·2006
Near-tetraploid acute myeloid leukemias: an EGIL retrospective study of 25 cases
Leukemia·2006· 23 cited
page 1 of 5Next →

Frequent Co-authors

Wolfgang E. Berdel(11), Bernhard Wörmann(10), Th. Büchner(9), Hubert Serve(9), M. von Eiff(8), Wolfgang Hiddemann(8), Thomas Büchner(7), J. van de Loo(6), N. Roos(5), Georg Maschmeyer(5), R. Rottmann(5), Michael Koenigsmann(4), G. Innig(4), Rolf M. Mesters(4), Carsten Müller‐Tidow(4), Elisabeth Oelmann(4), Thomas Büchner(4), Wolfgang Ludwig(4), W. Hiddemann(4), W. Fegeler(4)